Edition:
United States

Revenio Group Oyj (REG1V.HE)

REG1V.HE on Helsinki Stock Exchange

15.70EUR
11:59am EDT
Change (% chg)

€-0.06 (-0.38%)
Prev Close
€15.76
Open
€15.80
Day's High
€15.80
Day's Low
€15.68
Volume
3,974
Avg. Vol
19,163
52-wk High
€16.60
52-wk Low
€11.00

Latest Key Developments (Source: Significant Developments)

Revenio Group Q4 Net Sales Up At EUR ‍7.6​ Million
Thursday, 15 Feb 2018 02:00am EST 

Feb 15 (Reuters) - REVENIO GROUP OYJ ::Q4 NET SALES EUR ‍7.6​ MILLION VERSUS EUR 6.6 MILLION YEAR AGO.Q4 OPERATING PROFIT EUR ‍3.1​ MILLION VERSUS EUR 2.1 MILLION YEAR AGO.‍PROPOSE TO ANNUAL GENERAL MEETING OF MARCH 20, 2018 A DIVIDEND OF EUR 0.78​.‍NET SALES GROWTH IS EXPECTED TO REMAIN STRONG IN 2018​.2018 ‍PROFITABILITY IS EXPECTED TO REMAIN AT A HEALTHY LEVEL DESPITE RELATIVELY INCREASING GROWTH INVESTMENTS.​.  Full Article

Revenio Acquires Minority Interest In Oscare Medical
Monday, 11 Dec 2017 10:00am EST 

Dec 11 (Reuters) - Revenio Group Oyj ::REG-REVENIO GROUP CORPORATION: REVENIO ACQUIRES MINORITY INTEREST IN OSCARE MEDICAL OY.‍SIGNED AN AGREEMENT TO PURCHASE MINORITY INTEREST IN OSCARE MEDICAL OY, A STAKE OF 46.5% IN COMPANY​.‍FOLLOWING TRANSACTION, REVENIO GROUP CORPORATION WILL OWN 100% OF OSCARE MEDICAL OY​.‍REVENIO WILL MAKE IMPAIRMENT-RELATED ENTRIES IN FINANCIAL STATEMENTS FOR 2017​.- ‍ARRANGEMENT AND IMPAIRMENTS WILL HAVE ONE-OFF EFFECT OF AROUND EUR 1.4 MILLION ON OPERATING PROFIT FOR 2017​.‍ARRANGEMENT WILL HAVE NO EFFECT ON REVENIO'S FINANCIAL GUIDANCE FOR CURRENT YEAR.​.  Full Article

Revenio Group Q3 operating proft up at EUR 2.5 mln
Thursday, 26 Oct 2017 02:00am EDT 

Oct 26 (Reuters) - REVENIO GROUP OYJ ::Q3 NET SALES EUR ‍6.4​ MILLION VERSUS EUR 5.8 MILLION YEAR AGO.Q3 OPERATING PROFIT EUR ‍2.5​ MILLION VERSUS EUR 1.9 MILLION YEAR AGO.‍SAYS 2017 NET SALES GROWTH IS EXPECTED TO REMAIN STRONG PROFITABILITY​.  Full Article

Revenio Q2 net sales up at EUR 6.7 ‍​ million
Monday, 7 Aug 2017 02:00am EDT 

Aug 7 (Reuters) - REVENIO GROUP OYJ ::Q2 NET SALES EUR 6.7 ‍​ MILLION VERSUS EUR 5.8 MILLION YEAR AGO.Q2 OPERATING PROFIT EUR ‍​ 2.3 MILLION VERSUS EUR 1.7 MILLION YEAR AGO.SAYS PROFITABILITY IS EXPECTED TO REMAIN AT A HEALTHY LEVEL DESPITE GROWTH INVESTMENTS‍​.  Full Article

Revenio Q1 operating profit up at EUR 1.7 million
Thursday, 20 Apr 2017 02:02am EDT 

April 20 (Reuters) - REVENIO GROUP OYJ :Q1 NET SALES EUR 6.0 MILLION VERSUS EUR 5.2 MILLION YEAR AGO.Q1 OPERATING PROFIT EUR 1.7 MILLION VERSUS EUR 1.3 MILLION YEAR AGO.2017 NET SALES GROWTH IS EXPECTED TO REMAIN STRONG.2017 PROFITABILITY IS EXPECTED TO REMAIN AT A HEALTHY LEVEL DESPITE GROWTH INVESTMENTS.  Full Article

Revenio: FDA marketing approval granted in the US
Wednesday, 22 Mar 2017 03:30am EDT 

Revenio Group Oyj : Icare Finland Oy has received a marketing approval for Icare HOME tonometer in United States. . Received marketing approval does not have an affect on 2017 financial guidance. .Icare will immediately start preparations for launching product in United States..  Full Article

Revenio Q4 operating profit up at EUR 2.1 million
Thursday, 16 Feb 2017 02:00am EST 

Revenio Group Oyj : Q4 net sales 6.6 million euros ($7.00 million) versus 5.5 million euros year ago . Q4 operating profit 2.1 million euros versus 1.2 million euros year ago . Will propose dividend of 0.74 euro per share .Says net sales growth is expected to remain strong in 2017, profitability to remain at healthy level despite growth investments.  Full Article

BRIEF-Revenio Group Q1 Operating Profit EUR 2.1 Million

* Q1 NET SALES EUR 7.0 MILLION VERSUS EUR 6.0 MILLION YEAR AGO